中药治疗2型糖尿病合并帕金森病的机制研究
本文综述了2型糖尿病与帕金森病共病的共享病理机制,包括炎症、氧化应激、胰岛素抵抗、自噬受损、肠道菌群失调和铁死亡,涉及NLRP3、NF-κB、MAPK、Keap1/Nrf2/ARE、PI3K/AKT、AMPK/SIRT1和System XC--GSH-GPX4等信号通路。
要点
- T2DM与PD共享炎症、氧化应激、胰岛素抵抗等病理机制。
- 中药可作为T2DM与PD共病的辅助治疗潜力。
核心结论
- 中医药通过共享病理机制有效对抗T2DM和PD,提示其在治疗共病方面的潜力。
研究设计与样本
- 综述性研究,检索PubMed、Web of Science、Google Scholar和CNKI等电子数据库。
主要发现
- 炎症、氧化应激、胰岛素抵抗、自噬受损、肠道菌群失调和铁死亡是T2DM和PD的共享机制。
- 这些共享机制通过NLRP3炎症小体、NF-κB、MAPK、Keap1/Nrf2/ARE、PI3K/AKT、AMPK/SIRT1和System XC--GSH-GPX4信号通路介导。
临床怎么用
- 中药可能作为T2DM和PD共病的辅助治疗,针对共享机制进行干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Type 2 diabetes mellitus (T2DM) and Parkinson's disease (PD) are chronic conditions that affect the aging population, with increasing prevalence globally. The rising prevalence of comorbidity between these conditions, driven by demographic shifts, severely impacts the quality of life of patients, posing a significant burden on healthcare resources. Chinese herbal medicine has been used to treat T2DM and PD for millennia. Pharmacological studies have demonstrated that medicinal herbs effectively lower blood glucose levels and exert neuroprotective effects, suggesting their potential as adjunctive therapy for concurrent management of T2DM and PD. AIM OF THE STUDY: To elucidate the shared mechanisms underlying T2DM and PD, particularly focusing on the potential mechanisms by which medicinal herbs (including herbal formulas, single herbs, and active compounds) may treat these diseases, to provide valuable insights for developing therapeutics targeting comorbid T2DM and PD. MATERIALS AND METHODS: Studies exploring the mechanisms underlying T2DM and PD, as well as the treatment of these conditions with medicinal herbs, were extracted from several electronic databases, including PubMed, Web of Science, Google Scholar, and China National Knowledge Infrastructure (CNKI). RESULTS: Numerous studies have shown that inflammation, oxidative stress, insulin resistance, impaired autophagy, gut microbiota dysbiosis, and ferroptosis are shared mechanisms underlying T2DM and PD mediated through the NLRP3 inflammasome, NF-κB, MAPK, Keap1/Nrf2/ARE, PI3K/AKT, AMPK/SIRT1, and System XC--GSH-GPX4 signaling pathways. Thirty-four medicinal herbs, including 2 herbal formulas, 4 single herbs, and 28 active compounds, have been reported to potentially exert anti-T2DM and anti-PD effects by targeting these shared mechanisms. CONCLUSIONS: Traditional Chinese medicine effectively combats T2DM and PD through shared pathological mechanisms, highlighting their potential for application in treating these comorbid conditions.
引用
- Wang Y, Gao P, Wu Z, et al. Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study. J Ethnopharmacol. 2024. PMID: 39537117. doi:10.1016/j.jep.2024.119095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。